ATH alterity therapeutics limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-8

  1. 136 Posts.
    lightbulb Created with Sketch. 53
    Great reading, seems we could be through the biggest spending of the trials. And we're expecting around $4.0M R+D rebate sometime from now and Q1 25 aren't we?? That's how I interpret annual report page F-9 anyhow.

    So depending on expenses this quarter we could have around $9-10M in the bank when 201 is read-out. Bit of breathing space. Cheers
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.1¢
Change
0.000(0.00%)
Mkt cap ! $100.4M
Open High Low Value Volume
1.1¢ 1.1¢ 1.1¢ $88.06K 8.054M

Buyers (Bids)

No. Vol. Price($)
29 11330464 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 1574126 5
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.